Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats

Abstract

Endothelin-1 (ET-1), a potent vasoconstrictor, is believed to contribute to the pathogenesis of hypoxic pulmonary hypertension. Previously we demonstrated that contraction induced by ET-1 in intrapulmonary arteries (IPA) from chronically hypoxic (CH) rats occurred independently of changes in intracellular Ca²⁺concentration ([Ca²⁺]_i), suggesting that ET-1 increased Ca²⁺sensitivity. The mechanisms underlying this effect are unclear but could involve the activation of myosin light chain kinase, Rho kinase, PKC, or tyrosine kinases (TKs), including those from the Src family. In this study, we examined the effect of pharmacological inhibitors of these kinases on maximum tension generated by IPA from CH rats (10% O₂for 21 days) in response to ET-1. Experiments were conducted in the presence of nifedipine, an L-type Ca²⁺channel blocker, to isolate the component of contraction that occurred without a change in [Ca²⁺]_i. The mean change in tension caused by ET-1 (10⁻⁸M) expressed as a percent of the maximum response to KCl was 184.0 ± 39.0%. This response was markedly inhibited by the Rho kinase inhibitors Y-27632 and HA-1077 and the TK inhibitors genistein, tyrphostin A23, and PP2. In contrast, staurosporine and GF-109203X, inhibitors of PKC, had no significant inhibitory effect on the tension generated in response to ET-1. We conclude that the component of ET-1-induced contraction that occurs without a change in [Ca²⁺]_iin IPA from CH rats requires activation of Rho kinase and TKs, but not PKC.